Silverback Therapeutics
Silverback is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and fibrosis.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Silverback Therapeutics Information
Geographic Data
Address: 500 Fairview Avenue N
City: Seattle
State: WA
Zip: 98109
Country: US
Financial Info
Stage:
series c
Raised Last:
$85M
Raised Total:$221M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Silverback is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and fibrosis.
Contact Phone:
+12064562900
Contact Email:
Silverback Therapeutics went public on 12/3/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/3/2020
IPO Valuation:
$694M
Ticker Symbol:
SBTX
IPO Price:
$21/share
Amount Raised:
$278M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
